Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001415889-24-023005

Options or other derivatives

  • Director acquired 66,984 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dupont Jakob Director 2024-09-03 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Dupont Jakob Director 2024-09-03 Grant or award · Stock Option (Right to Buy) +16,984 16,984 D
Loading xslF345X05/form4-09062024_040947.xml…